Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on innovations addressing neuro-ophthalmic diseases with significant unmet medical needs, today ...

BUFFALO, N.Y. — A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a direct causal link with the drugs has not been established.

Having good eyesight makes performing your everyday tasks easier. But, vision issues are a common problem. More than 150 million Americans wear some form of corrective eyewear. Over half of adults ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio It is interesting to look back at the ...

The best way to understand where neuro-ophthalmology is and where it is going, according to one subspecialist, is to compare it to the state of parasitology 50 to 60 years ago, and the effort at that ...

—A large data analysis found a significantly heightened relative risk of optic neuritis in NMOSD, MOGAD, and other inflammatory diseases, supporting prompt evaluation of visual complaints in these ...

Treatment of the neuro-ophthalmologic sequelae of MS (such as oscillopsia from nystagmus or vision loss from optic neuritis) is anchored in treatment of the underlying disease, and supplemented by ...

A new report examined optic nerve lesion length, measured on brain magnetic resonance imaging, at the acute phase of ON in 51 individuals. Optic nerve lesion length was significantly associated with ...

Optic Neuritis: Clinical Features Optic neuritis refers to inflammation of the optic nerve. The term may be used broadly in reference to many causes of optic nerve inflammation including systemic ...